Clinical Trials Update: Dec. 20, 2006
Diabetic Foot Ulcers Diabetic Neuropathy Osteoporosis
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Diabetic Foot Ulcers
This research study will evaluate the safety and efficacy of three different doses of a topical investigational medication (tolbermin) versus placebo in people 18 to 80 years old with diabetic foot ulcers. Volunteers may qualify who have type 1 or 2 diabetes mellitus, at least one foot ulcer, and who do not have an active cancer or tumor of any kind, or a history of heart failure or pulmonary edema.
The research site is in Madison, Wis.
This research study will evaluate an investigational drug to treat diabetic peripheral neuropathic pain (pain in the feet, legs, hands or arms). Candidates 18-75 with diabetes mellitus (type 1 or type 2) who have had daily pain due to diabetic neuropathy for at least six months but not more than five years may be included.
The research sites are located across the United States.
This research study will compare an experimental medication for osteoporosis with a currently marketed osteoporosis medication. Post-menopausal women ages 50-75 years old may be eligible.
The research site is in Billings, Mont.
Copyright 2006 Thomson CenterWatch. All rights reserved.